Phenomics Australia. (2024). Developing reporter lines to enhance human kidney micro-organoids. Phenomics Australia.
url :
https://doi.org/10.82509/5j50-5273
Phenomics Australia. (2024). High-throughput identification of targets that improve kidney organoid generation protocols. Phenomics Australia.
url :
https://doi.org/10.82509/6xez-kr46
Phenomics Australia. (2024). A novel therapeutic intervention for genetic epilepsies using spider-venom peptides. Phenomics Australia.
url :
https://doi.org/10.82509/tn8t-3173
Phenomics Australia. (2024). Development of Humanised Mice to Improve the Translatability for Cardiopulmonary Disease. Phenomics Australia.
url :
https://doi.org/10.82509/5br4-d494
Phenomics Australia. (2024). FDA-approved therapeutic compound library screen to discover new drugs to treat ARID1A mutant ovarian cancer. Phenomics Australia.
url :
https://doi.org/10.82509/9k1d-b776
Phenomics Australia. (2024). Identification of personalised treatment strategies for breast cancer through high-throughput screening. Phenomics Australia.
url :
https://doi.org/10.82509/ww7y-kv68
Phenomics Australia. (2024). A high throughput human organoid model to measure effects of co-cultured immune cells. Phenomics Australia.
url :
https://doi.org/10.82509/8exm-f854
Phenomics Australia. (2024). Next-generation CRISPR therapeutics for autosomal dominant retinitis pigmentosa. Phenomics Australia.
url :
https://doi.org/10.82509/hz3j-jw23
Phenomics Australia. (2024). Deciphering the role of the kinome in skeletal muscle and their potential use as a therapeutic target in disease. Phenomics Australia.
url :
https://doi.org/10.82509/xsr0-z276
Phenomics Australia. (2024). Developing new tools to enable the translation of complement therapeutics for human disease. Phenomics Australia.
url :
https://doi.org/10.82509/3205-bb24
Phenomics Australia. (2024). A chloride ion channel as a novel therapeutic target for ischaemic heart disease. Phenomics Australia.
url :
https://doi.org/10.82509/rf2y-md51